Cliff Asness's CLB Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 49,818 shares of Core Laboratories Inc. (CLB) worth $798,582, representing 0.00% of the portfolio. First purchased in 2012-Q4, this long-term strategic position has been held for 31 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in CLB, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 37,576 shares. Largest reduction occurred in Q1 2018, reducing 48,101 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Core Laboratories (CLB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Core Laboratories (CLB) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +12,242 | Add 32.58% | 49,818 | $16.03 |
| Q3 2025 | +37,576 | New Buy | 37,576 | $12.36 |
| Q3 2020 | -22,967 | Sold Out | 0 | $0.00 |
| Q2 2020 | +5,043 | Add 28.14% | 22,967 | $19.07 |
| Q1 2020 | +17,924 | New Buy | 17,924 | $10.15 |
| Q4 2019 | -4,398 | Sold Out | 0 | $0.00 |
| Q3 2019 | +8 | Add 0.18% | 4,398 | $45.93 |
| Q2 2019 | -44 | Reduce 0.99% | 4,390 | $51.48 |
| Q1 2019 | -16,275 | Reduce 78.59% | 4,434 | $68.56 |
| Q4 2018 | +18,727 | Add 944.85% | 20,709 | $59.64 |
| Q3 2018 | +1,982 | New Buy | 1,982 | $116.04 |
| Q1 2018 | -48,101 | Sold Out | 0 | $0.00 |
| Q4 2017 | -18,528 | Reduce 27.81% | 48,101 | $109.54 |
| Q3 2017 | +9,549 | Add 16.73% | 66,629 | $98.70 |
| Q2 2017 | +6,921 | Add 13.80% | 57,080 | $101.26 |
| Q1 2017 | -19,779 | Reduce 28.28% | 50,159 | $115.51 |
| Q4 2016 | -37,069 | Reduce 34.64% | 69,938 | $120.03 |
| Q3 2016 | -20,095 | Reduce 15.81% | 107,007 | $112.33 |
| Q2 2016 | +32,540 | Add 34.41% | 127,102 | $123.89 |
| Q1 2016 | +23,331 | Add 32.75% | 94,562 | $112.41 |
| Q4 2015 | -1,192 | Reduce 1.65% | 71,231 | $108.74 |
| Q3 2015 | +33,290 | Add 85.07% | 72,423 | $99.80 |
| Q2 2015 | +27,633 | Add 240.29% | 39,133 | $114.05 |
| Q1 2015 | +8,200 | Add 248.48% | 11,500 | $104.52 |
| Q4 2014 | +3,300 | New Buy | 3,300 | $120.30 |
| Q1 2014 | -1,100 | Sold Out | 0 | $0.00 |
| Q4 2013 | +1,100 | New Buy | 1,100 | $190.91 |
| Q4 2012 | +2,500 | Add 0.00% | 2,500 | $109.20 |
Cliff Asness's Core Laboratories Investment FAQs
Cliff Asness first purchased Core Laboratories Inc. (CLB) in Q4 2012, acquiring 2,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Core Laboratories Inc. (CLB) for 31 quarters since Q4 2012.
Cliff Asness's largest addition to Core Laboratories Inc. (CLB) was in Q3 2025, adding 37,576 shares worth $464,440.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 49,818 shares of Core Laboratories Inc. (CLB), valued at approximately $798,582.
As of the Q4 2025 filing, Core Laboratories Inc. (CLB) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Core Laboratories Inc. (CLB) was 127,102 shares, as reported at the end of Q2 2016.